Takeda
Signal active
Investment Firm
Overview
Takeda researches, develops, manufactures, sells, markets, imports, and exports pharmaceutical drugs. They offer pharmaceuticals, therapeutics, oncology, and gastroenterology vaccines.
Highlights
Founded
1781
Industry
Biotechnology
Employees
10001+
Investment
51
Lead Investment
31
Exits
13
Stages
Late Stage Venture, Early Stage Venture, Seed, Private Equity
Investor Type
Venture Capital
Location
Asia
Contact Information
Social
Profile Resume
Takeda, established in 1781 and headquartered in Asia., specializes in Late Stage Venture, Early Stage Venture, Seed, Private Equity investments across Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics, Biopharma, Health Diagnostics, Wellness, Genetics, Clinical Trials. The organization boasts a portfolio of 51 investments, with an average round size of $44.4M and 13 successful exits. Their recent investments include Alnylam Pharmaceuticals, Naurex, Lundbeck, Shire, Baxter International. The highest investment round they participated in was $50.5B. Among their most notable exits are Alnylam Pharmaceuticals and Naurex. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
Investment portfolio
Takeda has made 51 investments. Their most recent investment was on Jun 20, 2024, when Ascentage Pharma raised $75.0M.
Takeda has made 8 diversity investments. Their most recent diversity investment was on Jan 05, 2017, when PvP Biologics raised $35.0M.
investments
51
Diversity investments
8
Lead investments
31
Number of exits
13
Investments
51
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Apr 03, 2023 | San Diego River Park Foundation | Recreation | null |
| Apr 03, 2023 | Mamas Kitchen | Health Care | null |
| Jul 24, 2023 | Crescendo Biologics | Biotechnology | 32.0M |
| Jun 20, 2024 | Ascentage Pharma | Biotechnology | 75.0M |
Crescendo BiologicsExits
13
Funding Timeline
Funding rounds
51
Investors
1
Funds
0
Funding Rounds
51
Takeda has raised 51 rounds. Their latest funding was raised on Jun 20, 2024 from a Post-IPO Equity - Ascentage Pharma round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Apr 03, 2023 | Grant - San Diego River Park Foundation | - | 0 | - |
| Apr 03, 2023 | Grant - Mamas Kitchen | - | 0 | - |
| Jul 24, 2023 | Venture Round - Crescendo Biologics | - | 32.0M | - |
| Jun 20, 2024 | Post-IPO Equity - Ascentage Pharma | - | 75.0M | - |
Investors
2
Takeda is funded by 2 investor(s). Bill & Melinda Gates Foundation Kantor is the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
Bill & Melinda Gates Foundation | No | Grant - Takeda | 38.0M |
| - | No | Grant - Takeda | 19.8M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.